| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9336487 | Brachytherapy | 2005 | 6 Pages |
Abstract
Dysuria is common after brachytherapy, but typically minimal in severity. Urethral doses did not predict for either dysuria severity or normalization. Although preimplant I-PSS was the strongest predictor of maximum dysuria and isotope the best predictor for dysuria normalization, robust predictors for brachytherapy-related dysuria were not identified.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Gregory S. Merrick, Wayne M. Butler, Kent E. Wallner, Zachariah A. Allen, Robert W. Galbreath, Jonathan H. Lief, Daniel J. Reed,